The FDA approved Etravirine Tablets 100 and 200 mg (Amneal Pharmaceutical) for the treatment of HIV.
Amneal’s etravirine is the first generic equivalent of Intelence (Janssen) and is indicated for the treatment of HIV-1 infection in treatment-experienced patients 6 years of age and older. Etravirine, which is a non-nucleoside reverse transcriptase inhibitor (NNRTI), is typically given with other antiretroviral medications. NNRTIs work by decreasing the viral load.
Severe,